Topical Rapamycin for Fibrofolliculomas

NCT00928798 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Birt-Hogg-Dubé Syndrome

Interventions

DRUG: Rapamycin
DRUG: placebo

Sponsor

Maastricht University Medical Center

Collaborators

[object Object]